Citations in PubMed

Primary Citation PubMed: 18656911 Citations in PubMed

PDB ID Mentions in PubMed Central Article count: 2

Citations in PubMed

This linkout lists citations, indexed by PubMed, to the Primary Citation for this PDB ID.

PDB ID Mentions in PubMed Central

Data mentions are occurrences of PDB IDs in the full text articles from the PubMedCentral Open Access Subset of currently about 1 million articles. For each article, the sentences containing the PDB ID are listed. Article titles can be filtered by keywords and sorted by year.

  • 3 per page
  • 5 per page
  • 10 per page
  • view all
  • Publication Year
  • Ascending
  • Descending

Prediction of cyclin-dependent kinase 2 inhibitor potency using the fragment molecular orbital method.

(2011) J Cheminform 3

PubMed: 21219630 | PubMedCentral: PMC3032746 | DOI: 10.1186/1758-2946-3-2

Entry Structure PDB Resolution (Å) IC 50 (μM) Δ G b i n d E x p t 1 a 2VTA 2 185.000 -5.292 2 a 2VTH 1.9 120.000 -5.558 3 a 2VTM 2.25 1000.000 -4.253 4 2VTJ b 7.000 -7.308 5 a ... VTJ 2.2 1.900 -8.110 6 a 2VTR 1.9 1.500 -8.256 7 a 2VTS 1.9 0.030 -10.665 8 2VTN b 3.000 -7.829 9 a 2VTI 2 0.660 -8.761 10 a 2VTL 2 97.000 -5.689 11 2VTN b 25.000 -6.524 12 2VTN b 85.000 -5.770 13 a 2VTN 2.2 0.850 -8.606 14 2VTP b 0.730 -8.699 15 2VTT b 1.600 -8.216 16 2VTT b 0.090 -9.988 17 a 2VTO 2.19 0.140 -9.716 18 a 2VTP 2.15 0.003 -12.082 19 2VTT b 0.025 -10.777 20 2VTT b 0.012 -11.229 21 2VTT b 0.019 -10.946 22 2VTT b 0.038 -10.519 23 a 2VTQ 1.9 0.140 -9.716 24 a 2VTT 1.68 0.044 -10.429 25 2VTT b 0.910 -8.564 26 2VTT b 0.052 -10.326 27 2VTT b 0.063 -10.208 28 a 2VU3 1.85 0.082 -10.045 Structures of the small molecule CDK2 inhibitors are shown, together with the reference PDB structure from which the compound was extracted, the resolution (Å) of the PDB structure, the ligand potency (IC 50 in μM) and the experimental free energy of binding (kcal/mol).

Publication Year: 2011


Molecular docking of 1H-pyrazole derivatives to receptor tyrosine kinase and protein kinase for screening potential inhibitors.

(2014) Bioinformation 10

PubMed: 25187680 | PubMedCentral: PMC4135288 | DOI: 10.6026/97320630010413

Docking evaluation for CDK2 inhibitors : Docking studies was performed for all the pyrazole derivatives with CDK2 (2VTO).

All the ligands were docked deeply within the binding pocket region of CDK2 (2VTO) showing hydrogen bonds with Ile 10, Lys 20, Lys 89 and Asp 145 Figure 3 ).

All three different cancers related proteins (PDB codes 2QU5, 2W1G and 2VTO) were retrieved from the Protein Data Bank [ 25 ].

Publication Year: 2014